These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 365798)

  • 21. [Correlations between laboratory and ultrasonic diagnosis and needle biopsy in chronic hepatitis and alcoholic cirrhosis].
    Pace M; Dotta C; Moretto F; Breda A; Rizzo A; Sanzuol F
    Minerva Med; 1990; 81(1-2):27-44. PubMed ID: 2179768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
    Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled clinical trials in diseases of the liver.
    Chalmers TC
    Prog Liver Dis; 1976; 5():450-6. PubMed ID: 775550
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience in the treatment of chronic hepatopathies with silymarin].
    Poser G
    Arzneimittelforschung; 1971 Aug; 21(8):1209-12. PubMed ID: 5110021
    [No Abstract]   [Full Text] [Related]  

  • 26. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD; Awasthi S; Jeyaseelan L
    Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone trial for NASH: results show promise.
    Lang L
    Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic infantile hepatitis with D-penicillamine (author's transl)].
    Weingärtner L; Metzke H; Rath FW; Baum WF; Preiss U; Heinrichs I
    Klin Padiatr; 1977 May; 189(3):211-9. PubMed ID: 559874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of liver puncture-biopsy for diagnosis, classification and treatment of chronic hepatitis].
    Degott C; Potet F
    Ann Pathol; 1983; 3(1):5-18. PubMed ID: 6573163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 31. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuing education. Clinical trials].
    Sökeland J
    Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies].
    Gili M; Lacalle JR; Velasco A
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):52-7. PubMed ID: 2095906
    [No Abstract]   [Full Text] [Related]  

  • 35. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC; Schmidt U; Dürr HK
    Med Klin; 1977 Mar; 72(12):513-8. PubMed ID: 840125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2228. PubMed ID: 11103264
    [No Abstract]   [Full Text] [Related]  

  • 37. [An attack on medical progress. Assertion of liability to punishment of controlled clinical therapeutic studies].
    Koller S
    Fortschr Med; 1977 Nov; 95(42):2570-4. PubMed ID: 334659
    [No Abstract]   [Full Text] [Related]  

  • 38. [Controlled clinical therapy study. Position papers on the contribution by S. Koller: Attack against progress in medicine--contention of illegality of controlled clinical therapy studies in Fortschr, Med. 95, 42:2570 (1977). Misleading the public].
    Fiebig U
    Fortschr Med; 1978 Dec; 96(47-48):2377-8. PubMed ID: 363579
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug trials: optimum time of publication.
    Moore S
    N Engl J Med; 1977 Apr; 296(17):1007-8. PubMed ID: 321959
    [No Abstract]   [Full Text] [Related]  

  • 40. [The controlled clinical study--proof or instrument for decision].
    Kienle G
    MMW Munch Med Wochenschr; 1978 Sep; 120(35):1115-8. PubMed ID: 308606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.